Zacks Research Has Bullish Estimate for COO FY2025 Earnings

Key Points

• Zacks Research has increased its FY2025 earnings estimate for Cooper Companies from $4.05 to $4.09 per share, higher than the current consensus of $3.98.
• Cooper Companies has announced a $2.00 billion stock buyback plan, indicating management's belief that the stock is undervalued.
• The company's recent quarterly earnings report showed an EPS of $1.10, exceeding estimates, while revenue grew by 5.7% year-over-year.

The Cooper Companies, Inc. (NASDAQ:COO - Free Report) - Equities researchers at Zacks Research increased their FY2025 earnings estimates for shares of Cooper Companies in a report issued on Wednesday, September 17th. Zacks Research analyst Team now anticipates that the medical device company will post earnings of $4.09 per share for the year, up from their previous forecast of $4.05. The consensus estimate for Cooper Companies' current full-year earnings is $3.98 per share. Zacks Research also issued estimates for Cooper Companies' Q2 2026 earnings at $1.04 EPS, Q3 2026 earnings at $1.14 EPS, Q4 2026 earnings at $1.17 EPS, FY2026 earnings at $4.35 EPS, Q1 2027 earnings at $1.10 EPS, Q2 2027 earnings at $1.15 EPS, Q3 2027 earnings at $1.25 EPS and FY2027 earnings at $4.77 EPS.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analysts' expectations of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business's revenue was up 5.7% compared to the same quarter last year. During the same period in the prior year, the company earned $0.96 EPS. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS.

COO has been the topic of a number of other reports. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating on the stock in a research note on Thursday, August 28th. Robert W. Baird decreased their target price on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research report on Thursday, August 28th. UBS Group raised shares of Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Loop Capital set a $100.00 price objective on shares of Cooper Companies in a research note on Tuesday, June 17th. Finally, Needham & Company LLC reiterated a "buy" rating and issued a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $86.64.

Cooper Companies Trading Down 0.2%

NASDAQ:COO traded down $0.17 during mid-day trading on Thursday, hitting $68.00. 2,880,009 shares of the stock traded hands, compared to its average volume of 3,539,709. The stock has a market capitalization of $13.52 billion, a price-to-earnings ratio of 33.50, a PEG ratio of 1.79 and a beta of 0.97. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $111.44. The firm's 50 day moving average is $70.54 and its two-hundred day moving average is $74.81. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Zions Bancorporation National Association UT purchased a new position in shares of Cooper Companies during the 1st quarter worth about $33,000. City Holding Co. acquired a new stake in Cooper Companies in the first quarter valued at approximately $34,000. J.Safra Asset Management Corp grew its position in Cooper Companies by 204.8% in the second quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company's stock valued at $36,000 after acquiring an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC acquired a new stake in shares of Cooper Companies during the second quarter worth approximately $36,000. Finally, GKV Capital Management Co. Inc. acquired a new stake in shares of Cooper Companies during the first quarter worth approximately $40,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, COO Daniel G. Mcbride acquired 3,000 shares of Cooper Companies stock in a transaction dated Tuesday, September 2nd. The stock was acquired at an average price of $65.04 per share, for a total transaction of $195,120.00. Following the transaction, the chief operating officer owned 63,120 shares of the company's stock, valued at $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Gerard H. Warner III acquired 1,450 shares of Cooper Companies stock in a transaction dated Friday, September 5th. The shares were bought at an average price of $69.23 per share, with a total value of $100,383.50. Following the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 15,975 shares of company stock worth $1,079,566. Insiders own 1.98% of the company's stock.

Cooper Companies declared that its board has approved a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board of directors believes its stock is undervalued.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.